Sara Gandini

ORCID: 0000-0002-1348-4548 · 2 papers in corpus

review 2019

The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis

Critical reviews in oncology/hematology ·doi:10.1016/j.critrevonc.2018.12.009

We conducted a meta-analysis of studies reporting on the risk of extra-ovarian malignancies among women with endometriosis. Summary relative risk (SRR) and 95% confidence intervals (CI) were calculated through random effect models. We explo…

2013

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer.

Breast cancer research : BCR ·doi:10.1186/bcr3439

IntroductionWe previously demonstrated that 1 or 5 mg per day of tamoxifen (T) given for four weeks before surgery reduces Ki-67 in breast cancer (BC) patients to the same extent as the standard 20 mg/d. Given the long half-life of T, a wee…